Evans-Cheung TC, et al. - For this investigation, researchers extracted demographic and hospitalization data from 161 people with Type 1 diabetes who received continuous subcutaneous insulin infusion (CSII) therapy between 2002 and 2013 at the Leeds Children and Young People's Diabetes Service for those aged < 20 years to assess HbA_1c values and hospitalization rates before, during and after CSII therapy. It was observed that the mean HbA_1c concentration decreased by 7 mmol/mol. The findings suggested that improvements were needed to reduce diabetic ketoacidosis hospitalizations for those new to the therapy despite significant reductions in HbA_1c levels for individuals treated with CSII. During CSII compared with the pre-CSII period, no difference in severe hypoglycaemia incidence rate was observed.